Institutional investors hold a majority ownership of MRK through the 75.22% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2016, these large investors purchased a net $20.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 10.1 Million shares of Merck
THE VANGUARD GROUP, INC. Bought 4.7 Million shares of Merck
ASSET MANAGEMENT ONE CO., LTD. Bought 4.5 Million shares of Merck